Diabetes research: A perspective from the National Institute of diabetes and digestive and kidney diseases

Diabetes

Volumn 62, Issue 2, 2013, Pages 320-326

  Fradkin, Judith E ^a   Rodgers, Griffin P ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; METFORMIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TEPLIZUMAB;

AUTOIMMUNITY; BIOINFORMATICS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CHILDHOOD OBESITY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC RISK; GENETIC VARIABILITY; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID STORAGE; LIPODYSTROPHY; MEDICAL EDUCATION; MULTICENTER STUDY (TOPIC); NATIONAL HEALTH ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATIENT CARE; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SELF CARE; SOCIAL STATUS;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INSULIN-SECRETING CELLS; MALE; MICE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (U.S.); OBESITY; PREVALENCE; UNITED STATES;

EID: 84873047977     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0269     Document Type: Review

References (12)

1. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Research Strategic Plan [Internet], 2011. National Institutes of Health, Bethesda, MD. Available from http://www2.niddk.nih.gov/AboutNIDDK/ ReportsAndStrategicPlanning/DiabetesPlan/PlanPosting.htm. Accessed December 13, 2012
2. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
3. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med 2008;35:357-363
4. Katula JA, Vitolins MZ, Rosenberger EL, et al. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project. Diabetes Care 2011;34:1451-1457
5. Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002
6. Moran A, Pekow P, Grover P, et al.; Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fi-brosis Related Diabetes Therapy Trial. Diabetes Care 2009;32:1783-1788
7. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
8. Pearson ER, Flechtner I, Njølstad PR, et al.; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfony-lureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467-477
9. Huang C, Florez JC. Pharmacogenetics in type 2 diabetes: potential implications for clinical practice. Genome Med 2011;3:76
10. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569
11. Chen H, Gu X, Liu Y, et al. PDGF signalling controls age-dependent proliferation in pancreatic b-cells. Nature 2011;478:349-355
12. Foster GD, Linder B, Baranowski T, et al.; HEALTHY Study Group. A school-based intervention for diabetes risk reduction. N Engl J Med 2010;363:443-453